Turning The Dial Up On Digital

The maturation of digital offerings, coupled with commercially and clinically successful partnerships, has enabled huge investments in the digital health industry.

Digital Consultation
• Source: Alamy

The reasons driving alliances and deals between pharma and digital health have been well documented; the need for innovation without internal capability, the need to remain commercially competitive through the addition of data and analytics, the weight of evidence to prove value to regulators and payers, and the evolution into patient-centric organizations through new forms of engagement.

Indeed, some companies are investing in complete internal digital transformation to become value-driven innovators. In December, Japanese pharma major

More from Deal-Making

More from In Vivo